Coral Laboratories share news and announcements
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹506.95.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹177 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 20 Oct 2026
- 9.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Sep 2026
- 0.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.40%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 20 Oct 2026
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 20 Oct 2026
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 Sep 2026
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,855
Coral Laboratories share news and announcements
720 announcements, routine notices left out, newest first. Page 3 of 15.
Aug 2024
14 Aug · Regulation 42 Under The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
6 Aug · Board meeting
Meeting on 9 Aug 20246 Aug · Board meeting
Meeting on 14 Aug 2024: quarterly results
Jul 2024
5 Jul · Board meeting
Meeting on 13 Jul 2024: final dividend5 Jul · Board meeting
May 2024
25 May · News Paper Advertisement
25 May · Disclosure under Regulation 30A of LODR
23 May · Related Party Transactions Details For The Half Year Ending On March 31, 2024
23 May · Results
16 May · Board meeting
Meeting on 23 May 2024: audited results
Apr 2024
24 Apr · Compliance Certificate For The Financial Year Ended March 31, 2024
24 Apr · Management
19 Apr · Board meeting
Meeting on 24 Apr 202416 Apr · Certificate Under Clause 40(9) Of The LODR
4 Apr · Board meeting
Meeting on 4 Apr 20244 Apr · Management
4 Apr · Board meeting
Mar 2024
29 Mar · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
21 Mar · Management
8 Mar · Board meeting
Feb 2024
29 Feb · Board meeting
Meeting on 8 Mar 202414 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results